Siolta Therapeutics announces positive results from phase 2 ADORED study of STMC-103H to prevent atopic diseases: San Carlos, California Wednesday, November 19, 2025, 18:00 Hrs [I ...

STMC-103H exhibited 64% reduction in the risk of atopic dermatitis in subjects who completed one year of treatment with strong and consistent effects ...

For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without asthma, across 64 sites in 12 European countries and assessed the efficacy and safety ...

MT-125, a selective inhibitor of non-muscle myosin II, targets glioblastoma's tumor proliferation and resistance mechanisms. The FDA's fast track designation aims to expedite MT-125's development and ...

JSKN003 has shown a 63% objective response rate and 7.7 months median progression-free survival in PROC patients, with higher efficacy in HER2-positive subgroups. The FDA's fast track designation ...

Key market opportunities in the India Ciprofloxacin market include addressing the high demand driven by widespread bacterial ...

Nektar Therapeutics has pivoted from oncology to focus on autoimmune and inflammatory diseases. Read why I rate NKTR stock a ...

Kelly Mann noticed her eyes kept getting red and thought she had a bad case of pink eye that wouldn't go away. It was ...

Share on Pinterest Eye health may hold the key to predicting heart disease and aging risk, according to new research. PeopleImages/Getty Images Scientists have known for some time now that the eyes ...

The twice-a-day cream can be used by adults affected by the inflammatory condition, which causes uncomfortable patches of ...